Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing. The breast, Dec. 2012, Vol. 21(6), p.724-29.
Pathmanathan, N., et al.
http://www.thebreastonline.com/article/S0960-9776(12)00187-7/abstract
The aim of this study was to determine the impact of universal HER2 testing on the clinico-pathologic profile of HER2+ breast cancer. Data were extracted from breast cancer pathology reports spanning two periods: before (2003/4, n = 379), and after (2008/9, n = 560) the introduction of universal testing.
